In the latest trading session,, 1.89 million SpringWorks Therapeutics Inc (NASDAQ:SWTX) shares changed hands as the company’s beta touched 0.69. With the company’s most recent per share price at $46.74 changing hands around $0.0 or 0.00% at last look, the market valuation stands at $3.52B. SWTX’s current price is a discount, trading about -32.65% off its 52-week high of $62.00. The share price had its 52-week low at $28.21, which suggests the last value was 39.64% up since then.
Analysts gave the SpringWorks Therapeutics Inc (SWTX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SWTX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
The company’s shares are showing year-to-date upside of 29.37%, with the 5-day performance at 0.06% in the green. However, in the 30-day time frame, SpringWorks Therapeutics Inc (NASDAQ:SWTX) is 1.34% up.
The consensus price target for the stock as assigned by Wall Street analysts is 62.5, meaning bulls need an upside of 25.22% from its recent market value. According to analyst projections, SWTX’s forecast low is 47 with 78 as the target high. To hit the forecast high, the stock’s price needs a -66.88% plunge from its current level, while the stock would need to soar -0.56% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -24.25%. The 2025 estimates are for SpringWorks Therapeutics Inc earnings to increase by 20.99%.
SWTX Dividends
SpringWorks Therapeutics Inc is expected to release its next quarterly earnings report in July.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 8.8294% or 6.54 million shares worth $246.53 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund . With 2.29 shares estimated at $107.17 million under it, the former controlled 3.04% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund held about 2.36% of the shares, roughly 1.78 shares worth around $83.09 million.
